Procos Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EFINACONAZOLE, with a corresponding US DMF Number 31933.
Remarkably, this DMF maintains an Active status since its submission on November 15, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 28, 2018, and payment made on December 15, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II